Oral Squamous Cell Carcinoma-Derived ANGPTL3 Induces Cancer Associated Fibroblastic Phenotypes in Surrounding Fibroblasts.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Dec 2022
Historique:
received: 11 08 2022
entrez: 29 12 2022
pubmed: 30 12 2022
medline: 3 1 2023
Statut: epublish

Résumé

Angiopoietin-like proteins (ANGPTLs) have emerged as both important regulator of lipid and glucose metabolism as well as insulin sensitivity. In particular, ANGPTL3 activity is one of the most important factors in cancer growth and invasion. Although ANGPTL3 have been studied in OSCC, but the role of ANGPTL3 between OSCC and CAFs has yet to be clearly defined. Thus, this study aimed to investigate the roles of ANGPTL3 in the differentiation of CAFs. For our study, we used hTERT-hNOFs to replace CAFs by coculturing them with oral squamous cell carcinoma (OSCC) cells. We did a microarray dataset analysis to investigate what factors secreted from OSCC cells can induce cancer associated fibroblastic phenotype in surrounding fibroblasts. The secreted factors were confirmed by RT-PCR, real-time PCR, and Western blot. ANGPTL3 has the most secreted factor derived from various oral cancer cells. To investigate the role of ANGPTL3 in CAFs, we treated rhANGPTL3 in hTERT-hNOFs. The fibroblasts showed an increase of tumor-promoting cytokines (IL-6 and IL-8) and myofibroblastic markers, such as α-SMA and FAP. In conclusion, our study reports the first evidence that ANGPTL3 plays a crucial role in tumor microenvironments by inducing CAF. Therefore, targeting ANGPTL3 may be promising treatment strategy for CAF-targeted therapy in CAF-rich tumors.

Identifiants

pubmed: 36580015
doi: 10.31557/APJCP.2022.23.12.4315
pmc: PMC9971477
pii:
doi:

Substances chimiques

ANGPTL3 protein, human 0
Angiopoietin-Like Protein 3 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4315-4322

Références

J Natl Cancer Inst. 2019 Sep 1;111(9):983-995
pubmed: 30816935
Cancer Cell. 2010 Feb 17;17(2):135-47
pubmed: 20138012
Int J Clin Exp Med. 2015 Sep 15;8(9):16101-6
pubmed: 26629119
Int J Mol Sci. 2020 Jun 23;21(12):
pubmed: 32585812
Int J Cancer. 2015 Dec 1;137(11):2545-57
pubmed: 26076896
Mol Cancer. 2019 Mar 30;18(1):70
pubmed: 30927908
Cancer Med. 2015 May;4(5):759-69
pubmed: 25644496
Oncogene. 2019 Jun;38(25):4887-4901
pubmed: 30816343
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Mol Cancer. 2021 Oct 11;20(1):131
pubmed: 34635121
Front Mol Biosci. 2022 Jan 04;8:796385
pubmed: 35059436
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Glob Cardiol Sci Pract. 2017 Mar 31;2017(1):e201706
pubmed: 28971105
Cancer Cell. 2011 Aug 16;20(2):229-45
pubmed: 21840487
J Cancer. 2017 Feb 25;8(5):761-773
pubmed: 28382138
Matrix Biol. 2018 Apr;67:90-106
pubmed: 29248556
J Biomed Sci. 2018 Mar 06;25(1):20
pubmed: 29506506
Nat Cell Biol. 2013 Jun;15(6):637-46
pubmed: 23708000
PLoS One. 2019 Mar 28;14(3):e0214553
pubmed: 30921404
Int J Cancer. 2010 Jul 15;127(2):332-44
pubmed: 19937793
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1742-6
pubmed: 21940333
Front Biosci (Landmark Ed). 2010 Jan 01;15(1):166-79
pubmed: 20036813
Nat Commun. 2020 Oct 9;11(1):5120
pubmed: 33037194
J Oral Pathol Med. 2017 Feb;46(2):82-88
pubmed: 27237745
Comput Struct Biotechnol J. 2018 Jul 27;16:279-287
pubmed: 30128085
Neoplasia. 2014 Nov 20;16(11):928-38
pubmed: 25425967
Front Endocrinol (Lausanne). 2014 Jan 23;5:4
pubmed: 24478758
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389861
Endocrinol Metab (Seoul). 2020 Dec;35(4):673-680
pubmed: 33161690
Cytokine. 2017 Aug;96:75-86
pubmed: 28371666
Front Cell Dev Biol. 2021 Jan 22;8:621070
pubmed: 33553157

Auteurs

Jue Young Kim (JY)

Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 06230, Republic of Korea.

Sook Moon (S)

Department of Dental Hygiene, Daejeon health institute of technology, Daejeon, 34504, Republic of Korea.

Dokyeong Kim (D)

Precision Medicine Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH